Cornus officinalis, as a medicinal plant, is rich in biologically active components, including polysaccharides, flavonoids, triterpenoids, and organic acids, which offer a variety of health benefits and significant potential for development in the food and pharmaceutical industries. Cornus officinalis polysaccharides (COPs) are considered among the primarily functional ingredients of the plant and are abundant in bioactivities. The present paper reviews the research conducted on the extraction, purification, structural properties, and biological activities of COPs. It also provides an overview of future development prospects, with a view to offering reference material for further development and research on COPs. In addition, the paper makes recommendations regarding theoretical preparations for the exploration of the application potential of COPs in the food industry and various other industrial fields.
Cistanche deserticola polysaccharide (CDP) exhibits pleiotropic bioactivities, yet its splenic-protective profile remains incompletely defined. Here, male ICR mice were challenged with cyclophosphamide (CTX) to establish an immunosuppressed model and concurrently treated with CDP. By integrating functional assays, splenic histopathology, and transcriptomic and proteomic analyses, we show that CDP dose-dependently restores splenic mass, rescues white-pulp atrophy, and suppresses megakaryocytic hyperplasia. Functionally, CDP rebalances pro-/anti-inflammatory cytokines, scavenges splenic ROS/MDA, and potentiates GSH-Px/SOD antioxidant capacity versus CTX alone. Multi-omics convergence (3103 DEGs; 1387 DEPs) delineated a CDP-distinctive signature related to innate immune recognition, oxidative stress buffering, and protease/ion-transport modules. Notably, transcriptional enrichment of neutrophil extracellular trap (NET)-associated proxies—synergized with NOD-like receptor/IL-17 signaling—suggests a putative innate-priming mechanism warranting functional validation, rather than confirmed pathway activation. Collectively, CDP mitigates CTX-induced splenic injury primarily through coupled redox restoration and transcriptional-level immune modulation.
Nitraria tangutorum Bobr. fruits are rich in bioactive polysaccharides (QBC) with high nutritional and developmental potential. This study optimized the ultrasonic-assisted extraction QBC via RSM, determining the optimal parameters to be 45 min, 59 °C, 19:1 mL/g, and 50% (150 W eq.), yielding 15.13%. Structurally, QBC exhibited a Mw of 1.997 × 105, Mw/Mn of 3.727, Rz of 15.6, and a monosaccharide molar ratio of rhamnose:arabinose:mannose:glucose:galactose = 1:1.12:1.66:7.3:1.86. In this study, the effects of QBC on oxidative stress markers and pro-inflammatory cytokines were evaluated via in vivo experiments. The results demonstrated that QBC significantly improved the thymic index and restored immune function. Specifically, QBC upregulated the expression of pro-inflammatory cytokines such as IL-6, TNF-α, and IFN-γ. The analysis of α/β diversity via 16S rRNA sequencing revealed that the CTX group induced a reduction in microbial richness, a more dispersed community structure, and increased intergroup dissimilarities. KEGG functional prediction indicated that polysaccharides regulated the ‘Infectious disease: parasitic’ and ‘Nitrotoluene degradation’ pathways, potentially by exerting their effects through metabolite-mediated immune regulation.
Polysaccharides (CDP-D2-N1) were extracted from Cistanche deserticola and used as an immunomodulatory substance to control inflammation and cytokines. This article chose LPS-induced inflammation model in RAW264.7 as the study subject and discloses the immune-inflammatory responses of CDP-D2-N1for lipopolysaccharide (LPS)-stimulated RAW264.7 cells. We investigated the screening of immunomodulatory activity of CDP-D2-N1 on LPS-induced RAW264.7 and the study of its pathway of action. CCK-8, qPCR and other tests were used to screen the CDP-D2-N1 with repairing effects on RAW264.7. The results show that CDP-D2-N1 pretreatment for 12 h at a concentration of 62.5–250 μg/mL improved the phagocytosis of RAW264.7, activated the expression of the TLR4 receptor, inhibited the expression of proinflammatory factors (TNF-α, IL-1, and IL-6) and the creation of iNOS, and modulated the NO of cell signaling molecules in RAW264.7 cells, thus improving the immunity of RAW264.7 cells and the activity of immune injury RAW264.7 cells. The combination of transcriptomics and p38 inhibitor analysis showed that CDP-D2-N1 could attenuate LPS-induced RAW264.7 cells’ immune injury by affecting the regulation of MAP3/6 expression in the TNF signaling pathway.